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Abstract The effect of the non-steroidal antioestrogens tamox-
ifen and toremifene on voltage-gated cationic currents was
examined in primary cultures of rat hypothalamic neurones and
the C1300 mouse neuroblastoma cell line using the whole-cell
patch clamp technique. When applied to the external bathing
solution both tamoxifen and toremifene were able to inhibit
TTX-sensitive sodium currents with IC50 values of 1^2 WM and
delayed rectifier type potassium currents (IC50, 2^3 WM).
However, only toremifene showed a significant inhibition of the
IA current (IC50 3 WM). Inhibition of voltage-gated cationic
currents was significantly impaired when tamoxifen was applied
in a serum-containing solution. The steroidal antioestrogen ICI
182,780 did not inhibit any of the currents at 10 WM.
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1. Introduction
Tamoxifen is a non-steroidal triphenylethylene antioestro-
gen [29] which has become a valuable adjunct in the treatment
of breast cancer. However, tamoxifen has been reported to
inhibit the function of a number of proteins located in the
plasma membrane, including multidrug resistance P-glycopro-
tein [3], protein kinase C [17], calmodulin [9], Na/Ca2 ex-
changer and Ca2-ATPase [14]. In addition, antioestrogens
have been shown to modulate both anionic and cationic mem-
brane conductances in a variety of cell types including potas-
sium currents in neuroblastoma cells [20], Ca2 currents in a
pituitary cell line [22] and chloride currents in epithelial cells
[24], ¢broblasts [10], lens ¢bres [30] and neuroblastoma cells
[4,32].
Tamoxifen and other antioestrogens, such as toremifene
[12] and ICI 182,780 [5], are being evaluated for their e⁄cacy
as chemoprophylactics for breast cancer in women [12]. Given
the diversity of putative cellular targets it is remarkable that
the number of clinical side e¡ects reported for antioestrogens
is so low [7,26]. In particular, a study of patients on high dose
tamoxifen treatment reported reversible neurological toxicity
[23].
The purpose of our study was to examine the selectivity of
action of non-steroidal antioestrogens on voltage-gated so-
dium and potassium channels in neurones from the hypothal-
amus, a region of the brain known to be sensitive to regula-
tion by oestrogens. Preliminary results have been presented
previously in abstract form [11].
2. Materials and methods
2.1. Cell culture
The hypothalamic neurones were removed from 15-day rat embryos
(Sprague-Dawley) into L-15 medium (Gibco BRL, Paisley, UK). A
single cell suspension was obtained by trituration through a ¢re-pol-
ished Pasteur pipette (10^12 passages). Cells were rinsed in MEM
without phenol red (Gibco) plus 10% foetal calf serum and 10% v/v
horse serum and plated (approx. 2U105 cells/ml) onto 35 mm petri
dishes precoated with polyornithine (100 Wg/ml) and laminin (5 Wg/
ml). After 24 h cells were bathed in MEM de¢ned medium [1] sup-
plemented with glucose (6%), glutamine (2 mM) and HEPES bu¡er
(5 mM). Cultures were maintained at 37‡C in 7.5% CO2 for up to
7 days. Experiments were performed 5^6 days after plating. Neurones
were identi¢ed by cell morphology and immuno£uorescence staining
with neurone-speci¢c MAP2 antibody. In the absence of mitotic in-
hibitors a mixture of astrocytes, neurones and occasional ¢broblasts
formed a monolayer of 50^70% con£uence within 5 days.
C1300 neuroblastoma cells [27] were maintained in culture using
Dulbecco’s modi¢ed Eagle’s medium (DMEM) without phenol red
supplemented with 10% (v/v) foetal calf serum and 2 mM L-glutamine.
Cells were grown at 37‡C in a humidi¢ed atmosphere of 5% CO2 in
air. Cells were subcultured into 35 mm culture dishes when con£uent
and used for patch clamp experiments within 48 h.
2.2. Electrophysiology
The intracellular solution contained (in mM) 140 KCl, 10 NaCl,
1 EGTA, 1.2 MgCl2, 10 HEPES, pH 7.4. and cells were bathed in
Hanks’ solution containing 140 NaCl, 10 HEPES, 5 KCl, 0.5 MgCl2,
1.2 CaCl2, pH 7.4. Whole-cell patch clamp recordings [8] were carried
out at room temperature. Drugs were applied to the bathing solution
using a U-tube applicator as described elsewhere [2]. Data were re-
corded and analysed using VGEN and WCP software (J. Dempster,
Strathclyde University, UK). All data were analysed without leak
subtraction. Remaining capacitative transients are removed from cer-
tain ¢gures to aid clarity. IC50 values were taken from the following
formula which was used to ¢t the curves to the inhibition plots:
y = [(a3d)/(1+(X/C)b)]+d where y is the percentage of the initial re-
sponse caused by a blocker at concentration X ; d is the estimated
maximal inhibition by the blocker; a is the response at X = 0; C is
the concentration of blocker required to cause 50% inhibition and b is
the Hill coe⁄cient.
Statistical comparisons were made using paired Student’s t-test us-
ing P6 0.05 as signi¢cant.
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3. Results
3.1. Sodium and potassium currents in embryonic hypothalamic
neurones
Fig. 1A illustrates typical Na and K currents in a 15-day
embryonic rat hypothalamic neurone recorded using quasi-
physiological conditions. The inward current was instantane-
ously and reversibly blocked by 0.1 WM tetrodotoxin (TTX,
n = 5; results not shown) without a¡ecting the outward cur-
rent. The use of 10 mM tetraethylammonium (TEA, n = 4)
and 2 mM 4-aminopyridine (4-AP, n = 5) revealed two potas-
sium currents: a 4-AP-sensitive IA current and a TEA-sensi-
tive delayed recti¢er current (results not shown). The activity
of the IA current could be markedly suppressed by alteration
of the holding voltage from 380 mV to 340 mV as shown in
Fig. 1B. From the I/V curve in Fig. 1C it can be seen that the
peak outward current obtained at 320 mV was exclusively IA,
without activation of DR-like current. The IA component
showed a voltage-independent inactivation time constant of
22 ms and a half-inactivation voltage of 375 mV (results
not shown).
3.2. E¡ect of antioestrogens on the potassium and sodium
currents in embryonic hypothalamic neurones
Two non-steroidal antioestrogens, tamoxifen and toremi-
fene, were tested for their ability to block the DR and IA
currents. Fig. 2A shows an example of the e¡ect of tamoxifen
(5 WM for 2 min) on Na and K currents recorded in a
hypothalamic neurone. Tamoxifen induced a substantial re-
duction of the steady-state outward current (mainly DR)
without a signi¢cant decrease in the transient component
(IA). The reduction in current amplitude occurred rapidly
upon the addition of the drug (inhibition reaching steady state
in 1^3 min) with only partial and delayed recovery of the
initial currents following withdrawal of the compounds (re-
sults not shown). The peak current was not signi¢cantly dif-
ferent from the control current recorded in the absence of
tamoxifen. The concentration-inhibition curves for toremifene
and tamoxifen obtained at the +20 mV peak and +60 mV
steady-state value (monitoring the IA and DR currents respec-
tively) are given in Fig. 2B,C. Tamoxifen and toremifene both
at 5 WM inhibited the steady-state currents (DR) by 74% and
89% respectively but no signi¢cant inhibition of the IA current
at +20 mV could be observed by tamoxifen at 1 WM and only
by 25% at 5 WM (Fig. 2C). Toremifene, in contrast, was able
to reduce the IA current by 75% at 5 WM (Fig. 2B). The IC50
values for toremifene were 3 WM for the +20 mV currents and
1 WM for the +60 mV currents.
The e¡ects of the antioestrogens on the sodium currents are
shown in Fig. 3. The INa current was elicited by a voltage
pulse from Vh =380 mV to 0 mV before and after the ad-
dition of 0.1 WM toremifene (Fig. 3A). The dose-response
curves obtained for tamoxifen and toremifene (Fig. 4B)
show that toremifene (IC50 = 1 WM) was a slightly more
potent blocker of the inward sodium current than tamoxifen
(IC50 = 2 WM).
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Fig. 1. Voltage-activated currents recorded under whole-cell patch clamp conditions from embryonic rat hypothalamic neurones (E15 days).
A: Typical trace of currents elicited by pulsing from 380 mV up to +60 mV in steps of 20 mV. B: Separation of IA and DR currents. Whole
cell currents obtained from a hypothalamic neurone hold at Vh =340 mV (left) or 380 mV (right). C: The corresponding current-voltage (I-V)
relationship obtained from the steady-state and peak responses as indicated by * in B. C. b, Vh =380 mV; F, Vh =340 mV. Note that the IA
currents obtained at 320 mV were uncontaminated by DR currents.
Fig. 2. E¡ect of tamoxifen on whole-cell currents of hypothalamic
neurones. A: Currents recorded using the voltage protocol as given
in Fig. 1A in control bathing solution and 2 min after the addition
of 5 WM tamoxifen. Note the relative sparing from inhibition of the
IA-like current. B and C: Concentration-response curves for block
of outward currents from hypothalamic neurones by (B) toremifene
and (C) tamoxifen (n = 3 for each point). E, +60 mV steady state;
b, +20 mV, peak.
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3.3. E¡ect of antioestrogens in the sodium and potassium
currents in C1300 neuroblastoma cells
To examine further the e¡ects of steroidal and non-steroidal
antioestrogens on neuronal voltage-gated currents, the C1300
neuroblastoma cell line was chosen. Previous studies [6,15,16]
have shown that the outward potassium currents in deriva-
tives of the C1300 neuroblastoma cell line are almost exclu-
sively DR and, thus, would facilitate the analysis of the e¡ect
of antioestrogens on DR currents in isolation. Using the same
voltage protocols as above, currents could be elicited from the
C1300 cells of similar characteristics to the voltage-gated so-
dium currents observed in the embryonic hypothalamic neuro-
nes along with outward currents resembling those carried by
DR potassium channels. Inward Na currents were com-
pletely blocked by 0.1 WM TTX (data not shown) and out-
ward K currents markedly reduced by 10 mM TEA (results
not shown). Both sodium and potassium currents were signi¢-
cantly blocked within 2 min following exposure to extracellu-
lar tamoxifen or toremifene (see Fig. 4A). The IC50 values
obtained for the sodium currents were 4.5 WM for tamoxifen
and 2.9 WM for toremifene (Fig. 4B). The IC50 value for both
of the antioestrogens was 2.2 WM against the potassium cur-
rents (Fig. 4C).
Tamoxifen and toremifene are triphenylethylene antioestro-
gens that are structurally unrelated to oestrogen. The e¡ect of
the steroidal analogue of oestrogen, the 7K-alkylamide deriv-
ative ICI 182,780, on the cationic currents in C1300 neuro-
blastoma cells was also investigated. Neither inward nor out-
ward currents were signi¢cantly altered by exposure to 10 WM
ICI 182,780 for up to 2^3 min (Fig. 5A). Following 2^3 min
washing in Hanks, subsequent exposure to tamoxifen signi¢-
cantly blocked both INa and IK currents at 5 WM. Mean
sodium and potassium currents measured in the absence and
in the presence of ICI 182,780 or tamoxifen are shown in
Fig. 5B.
3.4. E¡ect of serum on the channel blocking action of
tamoxifen in C1300 neuroblastoma cells
Tamoxifen has been reported to bind to rat serum low-
density lipoprotein [28]. The addition of 10% (v/v) foetal
calf serum to the external bathing solution containing 5 WM
tamoxifen prevented the inhibition of the inward sodium cur-
rents by tamoxifen (5.8 þ 5.3% compared with 86.5 þ 7.8%
block in the absence of serum; P = 0.01; n = 3). Similarly,
serum signi¢cantly reduced the blocking action of tamoxifen
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Fig. 4. E¡ect of antioestrogens on voltage-dependent outward cur-
rents in C1300 neuroblastoma cells. A: Representative family of
traces showing DR and sodium currents obtained using the voltage
protocol given in Fig. 1, before (control) and after exposure to ex-
tracellular 5 WM tamoxifen. Concentration-inhibition curves for the
inward sodium currents (B) and outward potassium currents (C) in
C1300 cells. Values were taken after 2 min exposure to antioestro-
gen. N = 3 for each data point and only one concentration was
tested per cell.
Fig. 5. E¡ect of steroidal and non-steroidal antioestrogens on
C1300 cells. A: A typical current observed in response to voltage
steps from Vh 380 to 320 and +60 mV in a C1300 cell. Addition
of 10 WM ICI 182,780 to the external bathing solution for up to 3
min had no signi¢cant e¡ect on the inward or outward currents
whereas subsequent addition of 5 WM toremifene markedly reduced
both currents by 2 min. B: Summary of the e¡ects of ICI 182,780
and toremeifene on the INa and IK currents in C1300 cells. The
mean values ( þ S.E.M.) are given for the inward sodium currents
(black columns, n = 4) and outward potassium currents (blank col-
umns, n = 4) in control (ctl) solution, after 3 min in 10 WM ICI
182,780 (ICI) and then, after washing in control solution, subse-
quent exposure to 5 WM toremifene for 2 min (tore). The asterisk
indicates that the values were signi¢cantly reduced compared with
the controls.
Fig. 3. E¡ect of antioestrogens on sodium currents. A: A trace ob-
tained by pulsing from 380 mV to 0 mV before and after 2 min in
0.1 WM toremifene. B: Concentration-inhibition curve for the two
antioestrogens on the sodium currents. Values were taken after 2
min exposure to the compounds. N = 3 for each point and only one
concentration was tested per cell.
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against potassium currents from 61.6 þ 5.4% in the absence of
serum to 19.4 þ 8.7% in the presence of serum (P = 0.002;
n = 4; values taken at 2 min).
4. Discussion
The data presented here show that tamoxifen and toremi-
fene, both non-steroidal antioestrogens, are able to inhibit
macroscopic voltage-gated cationic currents in two di¡erent
types of neuronal cells, primary cultures of hypothalamic neu-
rones and C1300 neuroblastoma cells. Tamoxifen and toremi-
fene (1) are equally potent blocking INa in hypothalamic
neurones and C1300 cells and (2) exhibit di¡ering a⁄nities
for two types of potassium currents, i.e. tamoxifen preferen-
tially inhibits DR currents while toremifene inhibits both DR
and IA currents. (3) The inhibitory e¡ect of tamoxifen was
impaired in the presence of serum.
It has been previously shown that tamoxifen blocks both
cationic and anionic currents [22,20,23,24,4,31,32]. Despite
this apparent wide spectrum of action, tamoxifen also shows
discrimination between di¡erent channels. It does not inhibit
resting potassium currents in non-neuronal cells [25] or
cAMP- and Ca2-dependent epithelial chloride channels [24].
Other tricyclic compounds such as chlorpromazine have
been shown to block calcium and potassium currents in ex-
citable cells [18,19,30]. It is interesting to note that the tricyclic
compounds demonstrated selectivity for di¡erent channel
types at low micromolar (10 WM) but not at higher concen-
trations [30]. Tricyclic antioestrogens are highly lipophilic and
will readily bind to plasma membranes [3]. Taking into ac-
count that the only structural di¡erence between tamoxifen
and toremifene is the presence of a chloride substitution on
one of the phenolic rings in toremifene, the extent to which
non-steroidal antioestrogens show selectivity for membrane
channels will require further studies.
Steroidal antioestrogens (e.g. ICI 182,780) had no discern-
ible e¡ect on the sodium or potassium currents recorded in
hypothalamic neurones and C1300 cells (this study) nor on
volume-activated chloride channels in C1300 neuroblastoma
cells [32]. However, a recent study by Ruehlmann et al. [21]
reported the ability of ICI 182,780 to modulate the activity of
potassium and calcium channels in vascular smooth muscle
cells, mimicking the e¡ect of oestradiol.
The rapid e¡ects of antioestrogens upon voltage-gated cat-
ionic currents suggest their interaction with either the channel
protein, directly or indirectly, rather than through a genomic
pathway. The fact that the inhibitory e¡ects of antioestrogens
took place in the absence of ATP or GTP in the pipette
solution supports the view that intracellular signalling is not
signi¢cant.
Neurological side e¡ects have been described in patients
receiving high dosage tamoxifen [23] but generally the toxicity
is low. Several reasons can be put forward to account for the
apparent discrepancy between in vitro and in vivo data. The
concentrations of free (unbound) drug are likely to be di¡er-
ent in di¡erent tissues such that insu⁄cient concentrations
will reach the neuronal membranes in vivo. Furthermore, ta-
moxifen will be protein bound in serum and, as is shown in
this study, the presence of serum reduces the e¡ectiveness of
tamoxifen as a channel blocker. Nevertheless accumulation
will occur with time which may reach appropriate concentra-
tions.
The electrical activity of hypothalamic neurones has been
shown to be modulated by oestrogens [13,15]. However, little
is known about the e¡ects of antioestrogens on hypothalamic
neurones. Although no side e¡ects that may be related to
impairment of hypothalamic function have been reported, it
is possible that long-term treatments may result in concentra-
tions high enough to induce symptoms.
The interference of tamoxifen and toremifene, but not ICI
182,780, with hypothalamic neuronal channels may have im-
portant implications for the design of antioestrogens devoid of
neuronal toxicity.
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